{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:49:39Z","timestamp":1791528579016,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11427-025-3308-1","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:56:15Z","timestamp":1780926975000},"page":"3260-3269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-density lipoprotein antioxidant function is associated with lipid profiles and lipid-lowering therapy"],"prefix":"10.1007","volume":"69","author":[{"given":"Hong-Yu","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Sheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ting","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Song","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"3308_CR1","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. (2024). 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care 47, S20\u2013S42.","journal-title":"Diabetes Care"},{"key":"3308_CR2","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacl.2016.08.003","volume":"10","author":"W Annema","year":"2016","unstructured":"Annema, W., Willemsen, H.M., de Boer, J.F., Dikkers, A., van der Giet, M., Nieuwland, W., Muller Kobold, A.C., van Pelt, L.J., Slart, R.H.J.A., van der Horst, I.C.C., et al. (2016). HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels. J Clin Lipidol 10, 1318\u20131328.","journal-title":"J Clin Lipidol"},{"key":"3308_CR3","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","volume":"108","author":"BJ Ansell","year":"2003","unstructured":"Ansell, B.J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S.T., et al. (2003). Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108, 2751\u20132756.","journal-title":"Circulation"},{"key":"3308_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161212799504803","volume":"18","author":"AS Antonopoulos","year":"2012","unstructured":"Antonopoulos, A.S., Margaritis, M., Lee, R., Channon, K., and Antoniades, C. (2012). Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des 18, 1519\u20131530.","journal-title":"Curr Pharm Des"},{"key":"3308_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-94-007-7920-4_9","volume":"77","author":"H Arai","year":"2014","unstructured":"Arai, H. (2014). Oxidative modification of lipoproteins. Subcell Biochem 77, 103\u2013114.","journal-title":"Subcell Biochem"},{"key":"3308_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/01.ATV.20.3.763","volume":"20","author":"A Artl","year":"2000","unstructured":"Artl, A., Marsche, G., Lestavel, S., Sattler, W., and Malle, E. (2000). Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol 20, 763\u2013772.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3308_CR7","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter, P.J., Caulfield, M., Eriksson, M., Grundy, S.M., Kastelein, J.J.P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.C., Waters, D.D., et al. (2007). Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357, 2109\u20132122.","journal-title":"N Engl J Med"},{"key":"3308_CR8","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1172\/JCI42946","volume":"121","author":"C Besler","year":"2011","unstructured":"Besler, C., Heinrich, K., Rohrer, L., Doerries, C., Riwanto, M., Shih, D.M., Chroni, A., Yonekawa, K., Stein, S., Schaefer, N., et al. (2011). Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 121, 2693\u20132708.","journal-title":"J Clin Invest"},{"key":"3308_CR9","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","volume":"365","author":"WE Boden","year":"2011","unstructured":"Boden, W.E., Probstfield, J.L., Anderson, T., Chaitman, B.R., Desvignes-Nickens, P., Koprowicz, K., McBride, R., Teo, K., and Weintraub, W. (2011). Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 365, 2255\u20132267.","journal-title":"N Engl J Med"},{"key":"3308_CR10","doi-asserted-by":"publisher","first-page":"155817","DOI":"10.1016\/j.metabol.2024.155817","volume":"154","author":"JX Chen","year":"2024","unstructured":"Chen, J.X., Li, Y., Zhang, Y.B., Wang, Y., Zhou, Y.F., Geng, T., Liu, G., Pan, A., and Liao, Y.F. (2024). Nonlinear relationship between high-density lipoprotein cholesterol and cardiovascular disease: an observational and Mendelian randomization analysis. Metabolism 154, 155817.","journal-title":"Metabolism"},{"key":"3308_CR11","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0022-2275(20)41119-8","volume":"36","author":"JK Christison","year":"1995","unstructured":"Christison, J.K., Rye, K.A., and Stocker, R. (1995). Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J Lipid Res 36, 2017\u20132026.","journal-title":"J Lipid Res"},{"key":"3308_CR12","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jacc.2017.08.053","volume":"70","author":"Y Dai","year":"2017","unstructured":"Dai, Y., Shen, Y., Li, Q.R., Ding, F.H., Wang, X.Q., Liu, H.J., Yan, X.X., Wang, L.J., Yang, K., Wang, H.B., et al. (2017). Glycated apolipoprotein A-IV induces atherogenesis in patients with CAD in type 2 diabetes. J Am Coll Cardiol 70, 2006\u20132019.","journal-title":"J Am Coll Cardiol"},{"key":"3308_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","volume":"222","author":"M de la Llera Moya","year":"2012","unstructured":"de la Llera Moya, M., McGillicuddy, F.C., Hinkle, C.C., Byrne, M., Joshi, M.R., Nguyen, V., Tabita-Martinez, J., Wolfe, M.L., Badellino, K., Pruscino, L., et al. (2012). Inflammation modulates human HDL composition and function in vivo. Atherosclerosis 222, 390\u2013394.","journal-title":"Atherosclerosis"},{"key":"3308_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/eci.12466","volume":"45","author":"K Distelmaier","year":"2015","unstructured":"Distelmaier, K., Wiesbauer, F., Blessberger, H., Oravec, S., Schrutka, L., Binder, C., Dostal, E., Schillinger, M., Wojta, J., Lang, I.M., et al. (2015). Impaired antioxidant HDL function is associated with premature myocardial infarction. Eur J Clin Invest 45, 731\u2013738.","journal-title":"Eur J Clin Invest"},{"key":"3308_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12944-021-01608-4","volume":"21","author":"SM Flaherty","year":"2022","unstructured":"Flaherty, S.M., Wood, E.K., Ryff, C.D., Love, G.D., Kelesidis, T., Berkowitz, L., Echevema, G., Rivera, K., Rigotti, A., and Coe, C.L. (2022). Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes. Lipids Health Dis 21, 18.","journal-title":"Lipids Health Dis"},{"key":"3308_CR16","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s11427-023-2688-8","volume":"67","author":"JJ Gao","year":"2024","unstructured":"Gao, J.J., Wu, F.Y., Liu, Y.J., Li, L., Lin, Y.J., Kang, Y.T., Peng, Y.M., Liu, Y.F., Wang, C., Ma, Z.S., et al. (2024). Increase of PCSK9 expression in diabetes promotes VEGFR2 ubiquitination to inhibit endothelial function and skin wound healing. Sci China Life Sci 67, 2635\u20132649.","journal-title":"Sci China Life Sci"},{"key":"3308_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1042\/CS20180306","volume":"132","author":"GR Geovanini","year":"2018","unstructured":"Geovanini, G.R., and Libby, P. (2018). Atherosclerosis and inflammation: overview and updates. Clin Sci 132, 1243\u20131252.","journal-title":"Clin Sci"},{"key":"3308_CR18","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1172\/JCI67478","volume":"123","author":"Y Huang","year":"2013","unstructured":"Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B.S., Gu, X., Fu, X., Wagner, M.A., Besler, C., Gerstenecker, G., et al. (2013). Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 123, 3815\u20133828.","journal-title":"J Clin Invest"},{"key":"3308_CR19","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.3390\/ijms24065747","volume":"24","author":"H Itabe","year":"2023","unstructured":"Itabe, H., and Obama, T. (2023). The oxidized lipoproteins in vivo: its diversity and behavior in the human circulation. Int J Mol Sci 24, 5747.","journal-title":"Int J Mol Sci"},{"key":"3308_CR20","first-page":"330","volume":"52","author":"Joint Committee on the Chinese Guidelines for Lipid Management","year":"2024","unstructured":"Joint Committee on the Chinese Guidelines for Lipid Management. (2024). Chinese guideline for lipid management (primary care version 2024) (in Chinese). Chin J Cardiol 52, 330\u2013337.","journal-title":"Chin J Cardiol"},{"key":"3308_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s11427-022-2381-7","volume":"67","author":"BA Kang","year":"2024","unstructured":"Kang, B.A., Li, H.M., Chen, Y.T., Deng, M.J., Li, Y., Peng, Y.M., Gao, J.J., Mo, Z.W., Zhou, J.G., Ou, Z.J., et al. (2024). High-density lipoprotein regulates angiogenesis by affecting autophagy via miRNA-181a-5p. Sci China Life Sci 67, 286\u2013300.","journal-title":"Sci China Life Sci"},{"key":"3308_CR22","doi-asserted-by":"publisher","first-page":"e111716","DOI":"10.1371\/journal.pone.0111716","volume":"9","author":"T Kelesidis","year":"2014","unstructured":"Kelesidis, T., Roberts, C.K., Huynh, D., Martinez-Maza, O., Currier, J.S., Reddy, S.T., and Yang, O.O. (2014). A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS One 9, e111716.","journal-title":"PLoS One"},{"key":"3308_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5245308","volume":"2020","author":"C Khatana","year":"2020","unstructured":"Khatana, C., Saini, N.K., Chakrabarti, S., Saini, V., Sharma, A., Saini, R.V., and Saini, A.K. (2020). Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev 2020, 1\u201314.","journal-title":"Oxid Med Cell Longev"},{"key":"3308_CR24","first-page":"1","volume":"7","author":"CE Kosmas","year":"2018","unstructured":"Kosmas, C.E., Martinez, I., Sourlas, A., Bouza, K.V., Campos, F.N., Torres, V., Montan, P.D., and Guzman, E. (2018). High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs Context 7, 1\u20139.","journal-title":"Drugs Context"},{"key":"3308_CR25","doi-asserted-by":"publisher","first-page":"101642","DOI":"10.1016\/j.redox.2020.101642","volume":"36","author":"HM Li","year":"2020","unstructured":"Li, H.M., Mo, Z.W., Peng, Y.M., Li, Y., Dai, W.P., Yuan, H.Y., Chang, F.J., Wang, T.T., Wang, M., Hu, K.H., et al. (2020). Angiogenic and antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients. Redox Biol 36, 101642.","journal-title":"Redox Biol"},{"key":"3308_CR26","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","volume":"376","author":"AM Lincoff","year":"2017","unstructured":"Lincoff, A.M., Nicholls, S.J., Riesmeyer, J.S., Barter, P.J., Brewer, H.B., Fox, K.A.A., Gibson, C.M., Granger, C., Menon, V., Montalescot, G., et al. (2017). Evacetrapib and cardiovascular outcomes in high-risk vascular disease. N Engl J Med 376, 1933\u20131942.","journal-title":"N Engl J Med"},{"key":"3308_CR27","doi-asserted-by":"publisher","first-page":"e30109","DOI":"10.1097\/MD.0000000000030109","volume":"101","author":"HT Liu","year":"2022","unstructured":"Liu, H.T., Jiang, Z.H., Yang, Z.B., and Quan, X.Q. (2022a). Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: a meta-analysis of 9 studies. Medicine 101, e30109.","journal-title":"Medicine"},{"key":"3308_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12944-022-01695-x","volume":"21","author":"SL Liu","year":"2022","unstructured":"Liu, S.L., Feng, B.Y., Song, Q.R., Zhang, Y.M., Wu, S.L., and Cai, J. (2022b). Neutrophil to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular outcomes in subjects with pre-diabetes: a large cohort study from China. Lipids Health Dis 21, 86.","journal-title":"Lipids Health Dis"},{"key":"3308_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach, F., Baigent, C., Catapano, A.L., Koskinas, K.C., Casula, M., Badimon, L., Chapman, M.J., De Backer, G.G., Delgado, V., Ference, B.A., et al. (2020). 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41, 111\u2013188.","journal-title":"Eur Heart J"},{"key":"3308_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41392-023-01558-6","volume":"8","author":"ZW Mo","year":"2023","unstructured":"Mo, Z.W., Peng, Y.M., Zhang, Y.X., Li, Y., Kang, B.A., Chen, Y.T., Li, L., Sorci-Thomas, M.G., Lin, Y.J., Cao, Y., et al. (2023). High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA. Sig Transduct Target Ther 8, 299.","journal-title":"Sig Transduct Target Ther"},{"key":"3308_CR31","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1016\/S0021-9258(17)44293-1","volume":"258","author":"RE Morton","year":"1983","unstructured":"Morton, R.E., and Zilversmit, D.B. (1983). Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J Biol Chem 258, 11751\u201311757.","journal-title":"J Biol Chem"},{"key":"3308_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4103\/hm.HM-D-24-00040","volume":"8","author":"LZ Munir","year":"2024","unstructured":"Munir, L.Z., and du Toit, E.F. (2024). Impact of chronic psychological stress on cardiovascular disease risk: a narrative review. Heart Mind 8, 268\u2013278.","journal-title":"Heart Mind"},{"key":"3308_CR33","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/01.RES.0000190634.60042.cb","volume":"97","author":"J Ou","year":"2005","unstructured":"Ou, J., Wang, J., Xu, H., Ou, Z., Sorci-Thomas, M.G., Jones, D.W., Signorino, P., Densmore, J.C., Kaul, S., Oldham, K.T., et al. (2005). Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor\/apolipoprotein A-I double-knockout mice on Western diet. Circ Res 97, 1190\u20131197.","journal-title":"Circ Res"},{"key":"3308_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.hrthm.2023.11.024","volume":"21","author":"N Pagonas","year":"2024","unstructured":"Pagonas, N., Mueller, R., Weiland, L., Jaensch, M., Dammermann, W., Seibert, F.S., Hillmeister, P., Buschmann, I., Christ, M., Ritter, O., et al. (2024). Oxidized high-density lipoprotein associates with atrial fibrillation. Heart Rhythm 21, 362\u2013369.","journal-title":"Heart Rhythm"},{"key":"3308_CR35","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.2147\/JIR.S406102","volume":"16","author":"X Pan","year":"2023","unstructured":"Pan, X., Zhang, X., Ban, J., Yue, L., Ren, L., and Chen, S. (2023). Association of neutrophil to high-density lipoprotein cholesterol ratio with cardiac ultrasound parameters and cardiovascular risk: a cross-sectional study based on healthy populations. J Inflamm Res Volume 16, 1853\u20131865.","journal-title":"J Inflamm Res Volume"},{"key":"3308_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/hm.HM-D-23-00047","volume":"8","author":"Y Pan","year":"2024","unstructured":"Pan, Y., Zhang, Z., Tan, X., and Zhu, J. (2024). Independent impact of brain-derived neurotrophic factor on cardiovascular prognosis in coronary heart disease patients: a prospective cohort study. Heart Mind 8, 206\u2013214.","journal-title":"Heart Mind"},{"key":"3308_CR37","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.jacc.2011.08.030","volume":"58","author":"PJ Patel","year":"2011","unstructured":"Patel, P.J., Khera, A.V., Jafri, K., Wilensky, R.L., and Rader, D.J. (2011). The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease. J Am Coll Cardiol 58, 2068\u20132075.","journal-title":"J Am Coll Cardiol"},{"key":"3308_CR38","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker, P.M., Danielson, E., Fonseca, F.A.H., Genest, J., Gotto Jr., A.M., Kastelein, J.J. P., Koenig, W., Libby, P., Lorenzatti, A.J., MacFadyen, J.G., et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359, 2195\u20132207.","journal-title":"N Engl J Med"},{"key":"3308_CR39","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","volume":"143","author":"A Rohatgi","year":"2021","unstructured":"Rohatgi, A., Westerterp, M., von Eckardstein, A., Remaley, A., and Rye, K.A. (2021). HDL in the 21st century: a multifunctional roadmap for future HDL research. Circulation 143, 2293\u20132309.","journal-title":"Circulation"},{"key":"3308_CR40","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak, M.J., Amann, K., Bangalore, S., Cavalcante, J.L., Charytan, D.M., Craig, J.C., Gill, J.S., Hlatky, M.A., Jardine, A.G., Landmesser, U., et al. (2019). Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74, 1823\u20131838.","journal-title":"J Am Coll Cardiol"},{"key":"3308_CR41","doi-asserted-by":"publisher","first-page":"e187889","DOI":"10.1172\/jci.insight.187889","volume":"10","author":"B Sasko","year":"2025","unstructured":"Sasko, B., Scharow, L., Mueller, R., Jaensch, M., Dammermann, W., Seibert, F.S., Hillmeister, P., Buschmann, I., Christ, M., Ritter, O., et al. (2025). Reduced high-density lipoprotein antioxidant function in patients with coronary artery disease and acute coronary syndrome. JCI Insight 10, e187889.","journal-title":"JCI Insight"},{"key":"3308_CR42","doi-asserted-by":"publisher","first-page":"e165370","DOI":"10.1172\/JCI165370","volume":"133","author":"M Sato","year":"2023","unstructured":"Sato, M., Neufeld, E.B., Playford, M.P., Lei, Y., Sorokin, A.V., Aponte, A.M., Freeman, L.A., Gordon, S.M., Dey, A.K., Jeiran, K., et al. (2023). Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease. J Clin Invest 133, e165370.","journal-title":"J Clin Invest"},{"key":"3308_CR43","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/antiox9111045","volume":"9","author":"N Sawada","year":"2020","unstructured":"Sawada, N., Obama, T., Mizuno, M., Fukuhara, K., Iwamoto, S., Aiuchi, T., Makiyama, T., and Itabe, H. (2020). Transfer and enzyme-mediated metabolism of oxidized phosphatidylcholine and lysophosphatidylcholine between low- and high-density lipoproteins. Antioxidants 9, 1045.","journal-title":"Antioxidants"},{"key":"3308_CR44","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","volume":"367","author":"GG Schwartz","year":"2012","unstructured":"Schwartz, G.G., Olsson, A.G., Abt, M., Ballantyne, C.M., Barter, P.J., Brumm, J., Chaitman, B.R., Holme, I.M., Kallend, D., Leiter, L.A., et al. (2012). Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 367, 2089\u20132099.","journal-title":"N Engl J Med"},{"key":"3308_CR45","first-page":"680","volume":"46","author":"Section of Interventional Cardiology of Chinese Society of Cardiology","year":"2018","unstructured":"Section of Interventional Cardiology of Chinese Society of Cardiology, Section of Atherosclerosis and Coronary Artery Disease of Chinese Society of Cardiology, and Specialty Committee on Prevention and Treatment of Thrombosis of Chinese College of Cardiovascular Physicians. (2018). Guideline on the diagnosis and treatment of stable coronary artery disease (in Chinese). Chin J Cardiol 46, 680\u2013694.","journal-title":"Chin J Cardiol"},{"key":"3308_CR46","first-page":"56325","volume":"128","author":"S Sen Roy","year":"2017","unstructured":"Sen Roy, S., Nguyen, H.C.X., Angelovich, T.A., Hearps, A.C., Huynh, D., Jaworowski, A., and Kelesidis, T. (2017). Cell-free biochemical fluorometric enzymatic assay for high-throughput measurement of lipid peroxidation in high density lipoprotein. J Vis Exp 128, 56325.","journal-title":"J Vis Exp"},{"key":"3308_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1021\/tx9003775","volume":"23","author":"B Shao","year":"2010","unstructured":"Shao, B., Oda, M.N., Oram, J.F., and Heinecke, J.W. (2010). Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. Chem Res Toxicol 23, 447\u2013454.","journal-title":"Chem Res Toxicol"},{"key":"3308_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-015-0221-4","volume":"14","author":"Y Shen","year":"2015","unstructured":"Shen, Y., Ding, F.H., Sun, J.T., Pu, L.J., Zhang, R.Y., Zhang, Q., Chen, Q.J., Shen, W.F., and Lu, L. (2015). Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 14, 52.","journal-title":"Cardiovasc Diabetol"},{"key":"3308_CR49","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1194\/jlr.R082735","volume":"59","author":"S Shrestha","year":"2018","unstructured":"Shrestha, S., Wu, B.J., Guiney, L., Barter, P.J., and Rye, K.A. (2018). Cholesteryl ester transfer protein and its inhibitors. J Lipid Res 59, 772\u2013783.","journal-title":"J Lipid Res"},{"key":"3308_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda, L.E., Rodr\u00edguez-Mor\u00e1n, M., and Guerrero-Romero, F. (2008). The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6, 299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"key":"3308_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert, J., Lehrke, M., Marx, N., Jankowski, J., and Noels, H. (2020). Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev 159, 4\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"3308_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jacc.2021.12.016","volume":"79","author":"NJ Stone","year":"2022","unstructured":"Stone, N.J., Smith Jr., S.C., Orringer, C.E., Rigotti, N.A., Navar, A.M., Khan, S.S., Jones, D.W., Goldberg, R., Mora, S., Blaha, M., et al. (2022). Managing atherosclerotic cardiovascular risk in young adults: JACC state-of-the-art review. J Am Coll Cardiol 79, 819\u2013836.","journal-title":"J Am Coll Cardiol"},{"key":"3308_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11427-024-2656-6","volume":"68","author":"WT Sun","year":"2025","unstructured":"Sun, W.T., Du, J.Y., Wang, J., Wang, Y.L., and Dong, E.D. (2025). Potential preservative mechanisms of cardiac rehabilitation pathways on endothelial function in coronary heart disease. Sci China Life Sci 68, 158\u2013175.","journal-title":"Sci China Life Sci"},{"key":"3308_CR54","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1194\/jlr.M059089","volume":"56","author":"T Vaisar","year":"2015","unstructured":"Vaisar, T., Tang, C., Babenko, I., Hutchins, P., Wimberger, J., Suffredini, A.F., and Heinecke, J.W. (2015). Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity. J Lipid Res 56, 1519\u20131530.","journal-title":"J Lipid Res"},{"key":"3308_CR55","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1172\/JCI118345","volume":"96","author":"BJ Van Lenten","year":"1995","unstructured":"Van Lenten, B.J., Hama, S.Y., de Beer, F.C., Stafforini, D.M., McIntyre, T.M., Prescott, S.M., La Du, B.N., Fogelman, A.M., and Navab, M. (1995). Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96, 2758\u20132767.","journal-title":"J Clin Invest"},{"key":"3308_CR56","doi-asserted-by":"publisher","first-page":"23283","DOI":"10.1038\/s41598-024-75453-7","volume":"14","author":"B Wang","year":"2024","unstructured":"Wang, B., Wang, J., Liu, C., and Hu, X. (2024). The potential of platelet to high-density lipoprotein cholesterol ratio (PHR) as a novel biomarker for heart failure. Sci Rep 14, 23283.","journal-title":"Sci Rep"},{"key":"3308_CR57","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12933-022-01615-4","volume":"21","author":"J Wang","year":"2022","unstructured":"Wang, J., Huang, X., Fu, C., Sheng, Q., and Liu, P. (2022). Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome. Cardiovasc Diabetol 21, 187.","journal-title":"Cardiovasc Diabetol"},{"key":"3308_CR58","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong, N.D., and Sattar, N. (2023). Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol 20, 685\u2013695.","journal-title":"Nat Rev Cardiol"},{"key":"3308_CR59","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s11427-025-2948-y","volume":"68","author":"S Xu","year":"2025","unstructured":"Xu, S., Liu, Y., Zhu, M., Chen, K., Xu, F., and Liu, Y. (2025). Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks. Sci China Life Sci 68, 2739\u20132754.","journal-title":"Sci China Life Sci"},{"key":"3308_CR60","first-page":"1","volume":"2022","author":"X Xu","year":"2022","unstructured":"Xu, X., Song, Z., Mao, B., Xu, G., and Garcia, V. (2022). Apolipoprotein A1-related proteins and reverse cholesterol transport in antiatherosclerosis therapy: recent progress and future perspectives. Cardiovasc Ther 2022, 1\u20139.","journal-title":"Cardiovasc Ther"},{"key":"3308_CR61","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1038\/s41598-017-03740-7","volume":"7","author":"K Yang","year":"2017","unstructured":"Yang, K., Liu, X., Liu, Y., Wang, X., Cao, L., Zhang, X., Xu, C., Shen, W., and Zhou, T. (2017). DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages. Sci Rep 7, 3296.","journal-title":"Sci Rep"},{"key":"3308_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/hm.HM-D-24-00027","volume":"8","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Xia, L., Li, Y., Duan, T., Lv, X., and Wang, Y. (2024). Effects of meditation and breathing therapy on anxiety improvement before and after percutaneous coronary intervention in patients with coronary artery disease: a prospective cohort study. Heart Mind 8, 239\u2013247.","journal-title":"Heart Mind"},{"key":"3308_CR63","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/biof.1819","volume":"48","author":"S Yazdandoust","year":"2022","unstructured":"Yazdandoust, S., Parizadeh, S.M.R., Ghayour-Mobarhan, M., Yaghmaei, P., and Sahebkar, A.H. (2022). High-density lipoprotein lipid peroxidation as a diagnostics biomarker in coronary artery disease. BioFactors 48, 634\u2013642.","journal-title":"BioFactors"},{"key":"3308_CR64","doi-asserted-by":"publisher","first-page":"e017712","DOI":"10.1161\/JAHA.120.017712","volume":"9","author":"M Zeitouni","year":"2020","unstructured":"Zeitouni, M., Clare, R.M., Chiswell, K., Abdulrahim, J., Shah, N., Pagidipati, N.P., Shah, S.H., Roe, M.T., Patel, M.R., and Jones, W.S. (2020). Risk factor burden and long-term prognosis of patients with premature coronary artery disease. J Am Heart Assoc 9, e017712.","journal-title":"J Am Heart Assoc"},{"key":"3308_CR65","doi-asserted-by":"publisher","first-page":"e38829","DOI":"10.1016\/j.heliyon.2024.e38829","volume":"10","author":"A Zhang","year":"2024","unstructured":"Zhang, A., Sun, W., Mei, L., Bai, M., Shi, W., Sun, C., and Qu, X. (2024). Neutrophil-to-HDL-C ratio as an inflammatory biomarker in patients with anxiety and obstructive coronary artery disease: a retrospective study. Heliyon 10, e38829.","journal-title":"Heliyon"},{"key":"3308_CR66","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.bbalip.2018.06.001","volume":"1863","author":"M Zhang","year":"2018","unstructured":"Zhang, M., Zhai, X., Li, J., Albers, J.J., Vuletic, S., and Ren, G. (2018). Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP). Biochim Biophys Acta 1863, 1082\u20131094.","journal-title":"Biochim Biophys Acta"},{"key":"3308_CR67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-023-01737-3","volume":"22","author":"R Zhang","year":"2023","unstructured":"Zhang, R., Shi, S., Chen, W., Wang, Y., Lin, X., Zhao, Y., Liao, L., Guo, Q., Zhang, X., Li, W., et al. (2023). Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol 22, 10.","journal-title":"Cardiovasc Diabetol"},{"key":"3308_CR68","first-page":"1","volume":"2022","author":"W Zhang","year":"2022","unstructured":"Zhang, W., Li, Z., Han, W.Q., Wang, Q.R., Wu, H.Y., Liu, X.H., Xing, K., Cheng, G., Chang, F.J., and Xu, B. (2022). The alteration of HDL in patients with AMI inhibited angiogenesis by blocking ERK1\/2 activation. Cardiovasc Ther 2022, 1\u20136.","journal-title":"Cardiovasc Ther"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-025-3308-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:02:11Z","timestamp":1791525731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-025-3308-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3308"],"URL":"https:\/\/doi.org\/10.1007\/s11427-025-3308-1","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. This study was approved by the Ethics Committee of the First Affiliated Hospital (2021\u2013189), Sun Yat-sen University and adhered to the principles of the Declaration of Helsinki. Informed consent was obtained from all the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}